Korczyn AD - Search Results

1

M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update.

Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD. Fisher A, et al. Among authors: korczyn ad. Ann N Y Acad Sci. 1996 Jan 17;777:189-96. doi: 10.1111/j.1749-6632.1996.tb34418.x. Ann N Y Acad Sci. 1996. PMID: 8624083 Review.

2

Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects.

Treves TA, Chandra V, Korczyn AD. Treves TA, et al. Among authors: korczyn ad. Neuroepidemiology. 1993;12(6):336-44. doi: 10.1159/000110336. Neuroepidemiology. 1993. PMID: 8309509 Review.

3

Selective lesion of neurons in primary cell cultures by MPTP and ethylcholine aziridinium ion (AF64A).

Amir A, Shahar A, Pittel Z, Korczyn AD, Fisher A, Heldman E. Amir A, et al. Among authors: korczyn ad. Prog Clin Biol Res. 1987;253:239-53. Prog Clin Biol Res. 1987. PMID: 3501589 No abstract available.

4

Parkinson's and Alzheimer's diseases: epidemiological comparison. 2. Persons at risk.

Treves TA, Chandra V, Korczyn AD. Treves TA, et al. Among authors: korczyn ad. Neuroepidemiology. 1993;12(6):345-9. doi: 10.1159/000110337. Neuroepidemiology. 1993. PMID: 8309510 Review.

5

Denbufylline in dementia: a double-blind controlled study.

Treves TA, Korczyn AD. Treves TA, et al. Among authors: korczyn ad. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):505-10. doi: 10.1159/000017197. Dement Geriatr Cogn Disord. 1999. PMID: 10559567 Clinical Trial.

6

Recruitment rate to drug trials for dementia of the Alzheimer type.

Treves TA, Verchovsky R, Klimovitsky S, Korczyn AD. Treves TA, et al. Among authors: korczyn ad. Alzheimer Dis Assoc Disord. 2000 Oct-Dec;14(4):209-11. doi: 10.1097/00002093-200010000-00004. Alzheimer Dis Assoc Disord. 2000. PMID: 11186598

7

Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease.

Kogan EA, Verchovsky RG, Neufeld MY, Klimovitsky SSh, Treves TA, Korczyn AD. Kogan EA, et al. Among authors: korczyn ad. J Neural Transm Suppl. 2007;(72):203-6. doi: 10.1007/978-3-211-73574-9_26. J Neural Transm Suppl. 2007. PMID: 17982896

8

APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia.

Treves TA, Bornstein NM, Chapman J, Klimovitzki S, Verchovsky R, Asherov A, Veshchev IO, Korczyn AD. Treves TA, et al. Among authors: korczyn ad. Alzheimer Dis Assoc Disord. 1996 Winter;10(4):189-91. doi: 10.1097/00002093-199601040-00003. Alzheimer Dis Assoc Disord. 1996. PMID: 8939277

9

Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls.

Neufeld MY, Rabey MJ, Parmet Y, Sifris P, Treves TA, Korczyn AD. Neufeld MY, et al. Among authors: korczyn ad. Electroencephalogr Clin Neurophysiol. 1994 Dec;91(6):407-12. doi: 10.1016/0013-4694(94)90162-7. Electroencephalogr Clin Neurophysiol. 1994. PMID: 7529680 Clinical Trial.

10

Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease.

Rabey JM, Treves TA, Neufeld MY, Orlov E, Korczyn AD. Rabey JM, et al. Among authors: korczyn ad. Neurology. 1995 Mar;45(3 Pt 1):432-4. doi: 10.1212/wnl.45.3.432. Neurology. 1995. PMID: 7898690 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page